Investigating alternative treatments for non-reponsive lymphoma patients
Mathias J Rummel
New endpoints in clinical trials to better serve patients
Elihu H. Estey
How to reduce anxiety levels in patients undergoing bone marrow biopsy
What does the TOURMALINE-MM2 study tell us about the use of ixazomib in multiple myeloma?
Allogeneic transplant in multiple myeloma: who should receive it and the future of transplant
Heinz Ludwig et al.